公与淑婷厨房猛烈进出,欧美dancepartyhd,他的舌头探进蜜源毛毛虫说说 ,肉浦团在线观看

苦杏仁苷

分析標準品,HPLC≥98%

Amygdalin

CAS號：29883-15-6

分子式：C20H27NO11

分子量：457.43

MDL：MFCD00006598

別名：扁桃苷;苦杏仁甙

產品介紹

 扁桃素是從薔薇果實的果核中分離的植物葡萄糖苷，例如杏，桃，杏仁，櫻桃和李子。

熔點：223-226℃

沸點：743.3℃ at 760 mmHg

比旋光度：-38.5 o (C=4, H2O)

外觀：斜方柱狀結晶

溶解性：DMSO:≥75mg/mL(163.96mM)

H2O:50mg/mL(109.31mM;Needultrasonic)

儲存條件：2-8℃

注意：部分產品我司僅能提供部分信息，我司不保證所提供信息的權威性，僅供客戶參考交流研究之用。

參考文獻(58篇)

58. [IF=7.6] Yujie Zhang et al."High-resolution mass spectrometry-based suspect and nontarget screening of natural toxins in foodstuffs and risk assessment of dietary exposure."ENVIRONMENTAL POLLUTION.2024 Nov;:125338

57. [IF=1.5] Ji Wanli et al."Revealing the Active Components and Therapeutic Targets of Sanao Decoction against Chronic Obstructive Pulmonary Disease Using Quantitative Analysis of Multi-Components by Single Marker and Network Pharmacology."JOURNAL OF CHROMATOGRAPHIC

56. [IF=4.8] Xiao Qiang et al."Flavonoids from Cerasus humilis seed coat alleviate constipation in mice: Role of AQP3/4 and c-Kit/SCF signaling pathways."Food Bioscience.2025 Jun;68:106643

55. [IF=5.3] Jiawei Bao et al."A novel efficient method for the simultaneous recycle of amygdalin and oil from bitter apricot kernels: Ultrasonication based on natural deep eutectic solvent."JOURNAL OF MOLECULAR LIQUIDS.2025 Jul;429:127592

54. [IF=5.3] Li Teng et al."Metabolomics integrated with network pharmacology of blood-entry constituents reveals the bioactive component of Xuefu Zhuyu decoction and its angiogenic effects in treating traumatic brain injury."Chinese Medicine.2024 Dec;19(1):1-16

53. [IF=6] Luyu Shan et al."Metabolism and release of characteristic components and profiles of enzymatic activities during fermentation of Massa Medicata Fermentata."LWT-FOOD SCIENCE AND TECHNOLOGY.2024 Oct;209:116793

52. [IF=5.3] Gao Jiaming et al."Buyang Huanwu decoction ameliorates myocardial injury and attenuates platelet activation by regulating the PI3 kinase/Rap1/integrin α(IIb)β(3) pathway."Chinese Medicine.2024 Dec;19(1):1-17

51. [IF=5] Luyao Liu et al."Targeted discovery of gut microbiome-remodeling compounds for the treatment of systemic inflammatory response syndrome."mSystems.

50. [IF=4.3] Hujun Du et al."Exploring the Underlying Mechanisms of Qingxing Granules Treating H1N1 Influenza Based on Network Pharmacology and Experimental Validation."Pharmaceuticals.2024 Jun;17(6):731

49. [IF=5.4] Yang Wang et al."Buyang huanwu decoction promotes remyelination via miR-760-3p/GPR17 axis after intracerebral hemorrhage."JOURNAL OF ETHNOPHARMACOLOGY".2024 Jun;328:118126

48. [IF=6] Dianwen Xu et al."Amygdalin Alleviates DSS-Induced Colitis by Restricting Cell Death and Inflammatory Response, Maintaining the Intestinal Barrier, and Modulating Intestinal Flora."Cells".2024 Jan;13(5):444

47. [IF=6] Rui Wang et al."Network Pharmacology-Based Approach reveals that Fructus mume exerts Therapeutic Effects against Ulcerative Colitis via the AGE/RAGE Signaling Pathway."Arabian Journal of Chemistry.2023 Dec;:105534

46. [IF=5.4] Menghan Cheng et al."A novel strategy of integrating network pharmacology and transcriptome reveals antiapoptotic mechanisms of Buyang Huanwu Decoction in treating intracerebral hemorrhage."JOURNAL OF ETHNOPHARMACOLOGY.10.1016/j.jep.2023.117123

45. [IF=5.4] Bo-Han Wang et al."Qufeng Xuanbi Formula inhibited benzo[a]pyrene-induced aggravated asthma airway mucus secretion by AhR/ROS/ERK pathway."JOURNAL OF ETHNOPHARMACOLOGY.10.1016/j.jep.2023.117203

44. [IF=5.4] Keyan Jiao et al."Glycosides of Buyang Huanwu decoction inhibits inflammation associated with cerebral ischemia-reperfusion via the PINK1/Parkin mitophagy pathway."JOURNAL OF ETHNOPHARMACOLOGY.2024 Jan;:117766

43. [IF=4.9] Zhang Min et al."Discovery and evaluation of active compounds from Xuanfei Baidu formula against COVID-19 via SARS-CoV-2 Mpro."Chinese Medicine.2023 Dec;18(1):1-14

42. [IF=5.4] Chang Zhou et al."Neuroprotective effects of Jie-du-huo-xue decoction on microglia pyroptosis after cerebral ischemia and Reperfusion——From the perspective of glial-vascular unit."JOURNAL OF ETHNOPHARMACOLOGY.2023 Aug;:116990

41. [IF=4.4] Mengyang Guo et al."Biotransformation of amygdalin by lactic acid bacteria fermentation."PROCESS BIOCHEMISTRY.2023 Sep;132:221

40. [IF=3.4] Wenmin Pi et al."Discovery, traceability, formation mechanism, metal and organic components analysis of supramolecules from Maxing Shigan decoction."JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS.2023 Sep;234:115532

39. [IF=2.745] Guoqin Zhang et al."Analysis of bitter almonds and processed products based on HPLC-fingerprints and chemometry."CHEMISTRY & BIODIVERSITY.2023 Feb;:

38. [IF=3.195] Yan, Fanchen et al."Glycoside combinations of Buyang Huanwu decoction ameliorate atherosclerosis via STAT3, HIF-1, and VEGF."NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY.2023 Jan;:1-17

37. [IF=6.056] Xianan Zhang et al."Effect of 1-methylcyclopropene on flat peach fruit quality based on electronic senses, LC-MS, and HS-SPME-GC-MS during shelf storage."LWT-FOOD SCIENCE AND TECHNOLOGY.2023 Jan;173:114388

36. [IF=2.65] Jing Zhou et al."Buyang Huanwu Decoction: A Traditional Chinese Medicine, Promotes Lactate-Induced Angiogenesis in Experimental Intracerebral Hemorrhage."Evidence-based Complementary and Alternative Medicine.2022 Oct 30;2022:4063315

35. [IF=5.168] Pan Wang et al."Discovery and characterization of novel ATP citrate lyase inhibitors from natural products by a luminescence-based assay."CHEMICO-BIOLOGICAL INTERACTIONS.2022 Nov;367:110199

34. [IF=5.988] Qihan Luo et al."Chang qing formula ameliorates colitis-associated colorectal cancer via suppressing IL-17/NF-κB/STAT3 pathway in mice as revealed by network pharmacology study."Frontiers in Pharmacology.2022; 13: 893231

33. [IF=6.656] Xinying Fu et al."Glycosides from Buyang Huanwu Decoction inhibit atherosclerotic inflammation via JAK/STAT signaling pathway."PHYTOMEDICINE.2022 Oct;105:154385

32. [IF=1.618] Zhang Guoqin et al."Study on the Correlation Between the Appearance Traits and Intrinsic Chemical Quality of Bitter Almonds Based on Fingerprint-Chemometrics."J Chromatogr Sci. 2022 Apr;:

31. [IF=2.193] Zhang Haibo et al.Systematic Study on a Quantitative Analysis of Multicomponents by Single Marker (QAMS) Method for Simultaneous Determination of Eight Constituents in Pneumonia Mixture by UPLC-MS/MS.J Anal Methods Chem. 2021;2021:8311588

30. [IF=3] Wan  Haoyu et al."Pharmacokinetics of seven major active components of Mahuang decoction in rat blood and brain by LC–MS/MS coupled to microdialysis sampling."N-S Arch Pharmacol. 2020 Aug;393(8):1559-1571

29. [IF=3.935] Pengcheng Huang et al."Correlation study between the pharmacokinetics of seven main active ingredients of Mahuang decoction and its pharmacodynamics in asthmatic rats."J Pharmaceut Biomed. 2020 May;183:113144

28. [IF=4.225] Wei  Wenyang et al."Screening of Antiviral Components of Ma Huang Tang and Investigation on the Ephedra Alkaloids Efficacy on Influenza Virus Type A."Front Pharmacol. 2019 Sep;0:961

27. [IF=1.773] Li-Hua ZHOU et al."Label-free quantitative proteomics reveals fibrinopeptide B and heparin cofactor II as potential serum biomarkers in respiratory syncytial virus-infected mice treated with Qingfei oral liquid formula."Chin J Nat Medicines. 2018 Apr;16:2

26. [IF=3.205] Dong-Dong Hu et al."Simultaneous determination of ten compounds in rat plasma by UPLC-MS/MS: Application in the pharmacokinetic study of Ma-Zi-Ren-Wan."J Chromatogr B. 2015 Sep;1000:136

25. [IF=3.414] Mengkai Zheng et al."Effects of herbal drugs in Mahuang decoction and their main components on intestinal transport characteristics of Ephedra alkaloids evaluated by a Caco-2 cell monolayer model."J Ethnopharmacol. 2015 Apr;164:22

24.  Zheng, Mengkai, et al. "Effects of herbal drugs in Mahuang decoction and their main components on intestinal transport characteristics of Ephedra alkaloids evaluated by a Caco-2 cell monolayer model." Journal of ethnopharmacology 164 (2015): 22-29.https:##

23.  Zhou, Li-Hua, et al. "Label-free quantitative proteomics reveals fibrinopeptide B and heparin cofactor II as potential serum biomarkers in respiratory syncytial virus-infected mice treated with Qingfei oral liquid formula." Chin J Nat Med 16 (2018): 241-25

22.  Zhou, Li-Hua, et al. "Label-free quantitative proteomics reveals fibrinopeptide B and heparin cofactor II as potential serum biomarkers in respiratory syncytial virus-infected mice treated with Qingfei oral liquid formula." Chin J Nat Med 16 (2018): 241-25

21.  王盼,儲全根,軒云,蔡正銀.抵當陷胸湯HPLC-MS指紋圖譜研究[J].時珍國醫國藥,2020,31(12):2937-2940.

20.  陳開瓊,楊其芳,茍琪,呂燕,劉建利.枸杞枝葉中乳酸菌的分離及其在徒長枝青貯中的應用評價[J].中國農業科技導報,2021,23(02):193-201.

19.  薛夢潔,于卉娟,王璐瑤,柴欣,楊靜,王躍飛.血府逐瘀湯提取過程中成分的量變規律研究[J].天津中醫藥,2021,38(01):109-112.

18.  王詩洋,王梟,徐祖清,劉悅,孔繁利.苦杏仁苷通過抑制氧化應激及炎癥反應減輕四氯化碳誘導的大鼠肝纖維化作用[J].現代免疫學,2020,40(06):471-475+481.

17.  劉月波  章小敏  洪冰 等. HPLC-DAD法比較不同劑型麻黃湯及其拆方中有效成分含量[J]. 中國中醫藥科技  2020(1).

16.  萬嘉洋, 田彥芳, 萬海同,等. 麻黃湯有效組分配伍在發熱大鼠體內的藥動學研究[J]. 中國中藥雜志, 2019(10).

15.  馮倫元, 何臘平, 李翠芹,等. 貴州傳統發酵豆制品中水解銀杏黃酮苷的微生物β-葡萄糖苷酶篩選[J]. 微生物學報, 2020(2).

14.  楊爽, 何妍茜, 楊潔,等. 感冒軟膠囊質量標準提高的研究[J]. 時珍國醫國藥, 2013, 24(008):1930-1932.

13.  陳俊怡, 賈天柱. 對苦杏仁燀炒炮制意義的商榷[J]. 亞太傳統醫藥, 2012, 08(006):48-50.

12.  楊麗,李瑩,王清嫻,孫勇兵,劉灣,李文宏.麻黃-杏仁藥對配比與有效成分含量變化規律研究[J].中國當代醫藥,2017,24(05):4-7+11.

11.  敖波, 侯永春, 賴珍珍,等. 麻黃-杏仁藥對成分-效應間變化規律[J]. 中成藥, 2018(6).

10.  謝婧, 張志, 李聽弦,等. 郁李仁不同炮制品及其水煎液中苦杏仁苷的含量比較[J]. 中國醫院藥學雜志, 2018(19).

9.  謝朝暉, 李鑫, 李文博,等. 超聲波法提取山杏仁中苦杏仁苷的單因素試驗研究[J]. 河南城建學院學報, 2012, 21(002):31-38.

8.  孫萌, 葉麗琴, 劉海嬌,等. 歐李種質資源評價研究[J]. 中藥材, 2017, 40(001):54-57.

7.  卞曉坤, 錢大瑋, 段金廒,等. 桃仁與山桃仁化學成分比較研究[J]. 藥物分析雜志, 2020, 040(001):123-131.

6.  劉策, 2], 曹清明,等. 杏仁皮的苦杏仁苷含量測定及脫毒工藝探究[J]. 食品研究與開發, 2015(3):59-63.

5.  許照, 肖雄, 黃剛,等. 基于含藥腸吸收液的麻黃-杏仁藥對物質基礎與作用機制分析[J]. 中國實驗方劑學雜志, 2018, 024(006):1-6.

4.  陳銘中  鐘旭美  劉和平 等. 發酵青梅酒脫苦工藝的優化[J]. 食品研究與開發  2017(11):114-118.

3.  權博文  張慧文  劉廣達 等. 十種產地扁桃的HPLC指紋圖譜比較[J]. 中華中醫藥學刊  2018  36(12):2918-2921.

2.  劉瑞琛  劉冬科  李連 等. HPLC-MS/MS同時測定芪龍膠囊中6個有效成分的含量[J]. 藥物分析雜志  2020  v.40(05):36-42.

1.  李玲 張波 盧芳國 蔡亮 高強 胡玨 何谷良 吳濤.A型流感病毒對肺巨噬細胞自噬的影響及麻杏石甘湯含藥血清的干預作用[J].中國藥理學通報 2019 35(06):878-884.

從2011年開始我們致力于在生命科學領域、生物醫學實驗技術及論文潤色服務，協助客戶各類實驗服務及論文潤色十余年，是您值得信賴的科研合作伙伴!

如果您受時間、試驗條件等限制而無法完成您的課題研究，歡迎您與我們聯系。

實驗技術服務：